September 15, 2017
EMA’s CHMP says No to Santhera’s Raxone in DMD, appeal on the way
Santhera Pharmaceuticals said on Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
September 15, 2017
Nordic Star Awards was presented at the NLSDays conference
Herantis Pharma, Targovax, Pelago get the Nordic Stars Award at the Nordic Life Sciences Days in Malmö, Sweden. Nordic Stars…
September 14, 2017
Novartis’s adalimumab offers alternative for patients with immunological diseases
Sandoz, a Novartis division has reported new data on its proposed biosimilar adalimumab.
September 13, 2017
Biocartis, Genomic Health bring together their Oncotype DX breast recurrence score test and Idylla platform
Biocartis and Genomic Health have entered a deal to develop an IVD version of the Oncotype DX Breast Recurrence Score…
September 12, 2017
GSK progresses regulatory filings for treating COPD with mepolizumabthis in 2017
GlaxoSmithKline has published full results from the phase III studies for mepolizumab in chronic obstructive pulmonary disease (COPD). For people living…
September 12, 2017
HanAll Biopharma, Harbour BioMed team up to make and sell dry eye and other inflammatory diseases products
HanAll Biopharma and Harbour BioMed on Tuesday announced agreeing to produce and sell HanAll’s two novel biologics, in Greater China, including Hong Kong, Macau and Taiwan,…
September 12, 2017
Cardiome Pharmato to sell Basilea Pharmaceutica’s antibiotic in Nordic Europe and Israel
Basilea Pharmaceutica’s Basilea Pharmaceutica International Ltd. has entered into a distribution agreement with Cardiome Pharma Corp. for Basilea’s antibiotic Zevtera/Mabelio (ceftobiprole) in Europe (excluding Nordic countries) and Israel.
September 12, 2017
Sandoz proposed biosimilar rituximab accepted for review by the FDA
Rituxan is used to treat blood cancers including non-Hodgkin’s lymphoma (follicular lymphoma and diffuse large B-cell lymphoma) and chronic lymphocytic leukemia, as well as immunological diseases such as rheumatoid arthritis.
September 12, 2017
TiGenix CEO welcomes two new team members in US
Belgian biopharmaceutical stem cells focused company TiGenix NV has made two senior appointments to reinforce its U.S. operations, who will both…
September 11, 2017
Piramal Pharma Solutions name chief operating officer
Piramal Pharma Solutions (PPS), part of Piramal Enterprises Limited, has appointed John Fowler as its Chief Operating Officer last week. Fowler…